Intercept to Announce Second Quarter 2022 Financial Results on August 3, 2022
July 27 2022 - 8:00AM
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat progressive
non-viral liver diseases, will announce its second quarter 2022
financial results prior to market open on Wednesday, August 3,
2022. The announcement will be followed by a conference call and
audio webcast hosted by Intercept management at 8:30 a.m.
ET to discuss the results.
Participants can access the conference call live via webcast
which will be available on the investor page of our website at
http://ir.interceptpharma.com. Participants who wish to ask a
question may register here to receive dial-in numbers and a unique
pin to join the call. While not required, it is recommended you
join 10 minutes prior to the event's start. A replay of the call
will be available on our website shortly following the completion
of the call and will be available for one year.
About Intercept Intercept is a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics to treat progressive
non-viral liver diseases, including primary biliary cholangitis
(PBC) and nonalcoholic steatohepatitis (NASH). For more
information, please visit www.interceptpharma.com or
connect with the company on Twitter and LinkedIn.
Contact For more information about
Intercept, please contact:
For investors: Nareg Sagherian, Executive Director, Global
Investor Relations investors@interceptpharma.com
For media: Karen Preble, Executive Director, Global
Corporate Communications media@interceptpharma.com
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intercept Pharmaceuticals (NASDAQ:ICPT)
Historical Stock Chart
From Sep 2023 to Sep 2024